Style | Citing Format |
---|---|
MLA | Shahsavari F, et al.. "Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer." Journal of Radioanalytical and Nuclear Chemistry, vol. 332, no. 7, 2023, pp. 2409-2417. |
APA | Shahsavari F, Bakhshi Kashi M, Farzanefar S, Eppard E, Vahidfar N (2023). Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer. Journal of Radioanalytical and Nuclear Chemistry, 332(7), 2409-2417. |
Chicago | Shahsavari F, Bakhshi Kashi M, Farzanefar S, Eppard E, Vahidfar N. "Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer." Journal of Radioanalytical and Nuclear Chemistry 332, no. 7 (2023): 2409-2417. |
Harvard | Shahsavari F et al. (2023) 'Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer', Journal of Radioanalytical and Nuclear Chemistry, 332(7), pp. 2409-2417. |
Vancouver | Shahsavari F, Bakhshi Kashi M, Farzanefar S, Eppard E, Vahidfar N. Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer. Journal of Radioanalytical and Nuclear Chemistry. 2023;332(7):2409-2417. |
BibTex | @article{ author = {Shahsavari F and Bakhshi Kashi M and Farzanefar S and Eppard E and Vahidfar N}, title = {Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer}, journal = {Journal of Radioanalytical and Nuclear Chemistry}, volume = {332}, number = {7}, pages = {2409-2417}, year = {2023} } |
RIS | TY - JOUR AU - Shahsavari F AU - Bakhshi Kashi M AU - Farzanefar S AU - Eppard E AU - Vahidfar N TI - Radiopharmaceuticals for Sentinel Lymph Node Identification in Breast Cancer JO - Journal of Radioanalytical and Nuclear Chemistry VL - 332 IS - 7 SP - 2409 EP - 2417 PY - 2023 ER - |